Overview

Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine

Status:
RECRUITING
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
The investigators are evaluating postoperative outcomes in patients undergoing hip replacement surgery performed with either spinal or general anesthesia, who also receive a suprainguinal fascia iliaca block using either perineural ropivacaine alone or ropivacaine combined with dexmedetomidine.
Phase:
PHASE4
Details
Lead Sponsor:
Rhode Island Hospital
Treatments:
Dexmedetomidine
Ropivacaine